Jason T. Gammack is the CEO of Ansa Biotechnologies, leveraging over 30 years of life sciences experience to commercialize the companys enzymatic DNA synthesis technology. He holds a BS in Biology from the University of California, Davis, and an MBA from Santa Clara University, focusing on fundraising, M&A, and scaling innovative biotech solutions.
Beyond his executive roles, Jason shows a strong interest in the broader scientific landscape, following major advancements at organizations like NASA and pharmaceutical leader Bristol Myers Squibb. This reflects a deep curiosity for pioneering research and cutting-edge technology across different scientific fields.
He believes that scientific progress is often hindered by inadequate tools, not by overly ambitious research goals.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Jason has no verified education history
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.